Inside-out vesicles expressing multi-drug resistance protein (MRP) 2 and MRP4: Evaluation using fluorescent and radiolabelled substrates

被引：0

|

作者：

Riches, Zoe ^{[1
]}

Pearce, Helen ^{[2
]}

Hawksworth, Gabrielle M. ^{[1
]}

机构：

[1] Univ Aberdeen, Sch Med & Dent, Div Appl Med, Aberdeen AB9 1FX, Scotland

[2] GSK, Brentford, England

来源：

TOXICOLOGY | 2010年 / 278卷 / 03期

关键词：

TRANSPORT; SURROGATE;

D O I：

10.1016/j.tox.2010.08.145

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：378 / 378

页数：1

相关论文

共 22 条

[21] Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one)
Mizuno, Naomi
Takahashi, Tsuyoshi
Kusuhara, Hiroyuki
Schuetz, John D.
Niwa, Takuro
Sugiyama, Yuichi
DRUG METABOLISM AND DISPOSITION, 2007, 35 (11) : 2045 - 2052
[22] Upregulation of Cyclooxygenase-2/Prostaglandin E-2 (COX-2/PGE(2)) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer
Kochel, Tyler J.
Goloubeva, Olga G.
Fulton, Amy M.
BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2016, 10 : 61 - 70